In this Q&A, our Director Jeremy Farrar speaks to the National Foundation for Infectious Diseases about his career and the people who have influenced him.
The text of our letter to Prime Minister Boris Johnson, calling on him to set out his vision for UK science as soon as possible.
The new PhD programmes in science that we’re funding combine scientific excellence with a commitment to improving the working environment for trainees.
Research culture is often underpinned by the decisions that funders make and how they make them. But what is the best way to decide who to fund?
Today, we’re pleased to launch new Research Enrichment awards. These extend our dedicated funding for public engagement to encompass open research, and diversity and inclusion.
Robert Kiley, Head of Open Research, and Jim Smith, Director of Science, discuss the steps Wellcome is taking to fulfil the principles of the San Francisco Declaration on Research Assessment (DORA).
To support the best science, the UK and EU must come to a mutually beneficial compromise, says Wellcome's Director Jeremy Farrar.
Three years on from an unprecedented epidemic in Central and South America, families affected by Zika are still benefiting from research studies supported since the outbreak began.
We’ve launched two new calls to fund international exchange programmes and research development activities for humanities and social science researchers around the world.
We're working hard to clarify what we hope the science review will achieve, how we’ll carry it out and who we’ll speak to.
This autumn we’ll announce new partnerships to fund innovative public engagement projects.
We’ve updated our bullying and harassment policy to set out how we expect the organisations we fund to handle cases of misconduct.
We’re changing how we award Biomedical Vacation Scholarships.
The PM's announcement of reforms to the immigration system for scientists is a step in the right direction. But alone it won't be enough to keep the UK as a global research leader following Brexit.
Wellcome has joined CSDR, a data-sharing initiative involving academic research funders and pharmaceutical companies. Jen O’Callaghan, from our Open Research team, explains why.
Alyson Fox, our Director of Grants, explains how Wellcome’s grant conditions and policies help great ideas to thrive.
Our investments portfolio grew to almost £25.9 billion by 30 September 2018, strengthening our ambition to spend more than £5 billion over five years on charitable activities.
Alyson Fox, our Director of Grants, explains why we’re changing our policy on transferring grants to ensure research can thrive in the UK, EU and beyond.
There has been lots of reaction to the changes we’re making to Wellcome’s open access policy. This is how we are addressing them.
We’re trying new ways to support researchers to deliver the best possible public engagement.